Aldeyra Therapeutics Inc ALDX:NASDAQ

Last Price$5.44NASDAQ Previous Close - Last Trade as of 4:00PM ET 9/23/22
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$5.21 (2)
Ask (Size)$5.46 (4)
Day Low / HighN/A - N/A
Volume430.2 K

View Biotechnology IndustryPeer Comparison as of 09/23/2022


Aldeyra Therapeutics Inc ( NASDAQ )

Price: $5.44
Change: -0.33 (5.72%)
Volume: 430.2 K
4:00PM ET 9/23/2022

BioXcel Therapeutics Inc ( NASDAQ )

Price: $11.54
Change: -0.41 (3.43%)
Volume: 253.4 K
4:00PM ET 9/23/2022

MiMedx Group Inc ( NASDAQ )

Price: $2.74
Change: -0.10 (3.52%)
Volume: 508.0 K
4:00PM ET 9/23/2022

Alpine Immune Sciences Inc ( NASDAQ )

Price: $6.89
Change: -0.11 (1.57%)
Volume: 189.6 K
4:00PM ET 9/23/2022

Scholar Rock Holding Corp ( NASDAQ )

Price: $6.45
Change: -0.97 (13.07%)
Volume: 444.2 K
4:00PM ET 9/23/2022

Read more news Recent News

Aldeyra Therapeutics On Track to File New Drug Application for Dry Eye Disease Drug Candidate in Q4
9:56AM ET 9/14/2022 MT Newswires

Aldeyra Therapeutics (ALDX) said Wednesday it remains on track to submit a new drug application for dry eye disease drug candidate reproxalap in Q4,...

Aldeyra Therapeutics Posts Wider Q2 Loss
1:51PM ET 8/05/2022 MT Newswires

Aldeyra Therapeutics (ALDX) reported Friday a Q2 net loss per share of $0.30, widening from a loss of $0.28 a year earlier. Analysts polled by Capital IQ...

-- Earnings Flash (ALDX) ALDEYRA THERAPEUTICS Posts Q2 Loss $-0.30
7:01AM ET 8/05/2022 MT Newswires


Sector Update: Health Care Stocks Lean Lower Premarket Tuesday
9:05AM ET 7/12/2022 MT Newswires

Health care stocks were leaning lower premarket Tuesday. The Health Care SPDR (XLV) was down 0.33% and the iShares NASDAQ Biotechnology Index (IBB) was...

Company Profile

Business DescriptionAldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA. View company web site for more details
Address131 Hartwell Avenue
Lexington, Massachusetts 02421
Number of Employees19
Recent SEC Filing09/14/20228-K
President, Chief Executive Officer & DirectorTodd C. Brady
Chief Financial Officer, Treasurer & VP-FinanceBruce Greenberg
Senior Vice President-Clinical DevelopmentJames A. Gow
Chief Development OfficerStephen G. Machatha

Company Highlights

Price Open$5.70
Previous Close$5.77
52 Week Range$2.36 - 9.74
Market Capitalization$317.3 M
Shares Outstanding58.3 M
SectorHealth Technology
Next Earnings Announcement10/27/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.14
Beta vs. S&P 500N/A
Net Profit MarginN/A
Return on Equity-33.47%

Analyst Ratings as of 06/29/2022

Consensus RecommendationConsensus Icon
Powered by Factset